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Abstract
Members of the IL-17 cytokine family play an important role in protection against pathogens through the induction of
different effector mechanisms. We determined that IL-17A, IL-17E and IL-17F are produced during the acute phase of T. cruzi
infection. Using IL-17RA knockout (KO) mice, we demonstrate that IL-17RA, the common receptor subunit for many IL-17
family members, is required for host resistance during T. cruzi infection. Furthermore, infected IL-17RA KO mice that lack of
response to several IL-17 cytokines showed amplified inflammatory responses with exuberant IFN-c and TNF production
that promoted hepatic damage and mortality. Absence of IL-17RA during T. cruzi infection resulted in reduced CXCL1 and
CXCL2 expression in spleen and liver and limited neutrophil recruitment. T. cruzi-stimulated neutrophils secreted IL-10 and
showed an IL-10-dependent suppressive phenotype in vitro inhibiting T-cell proliferation and IFN-c production. Specific
depletion of Ly-6G+ neutrophils in vivo during T. cruzi infection raised parasitemia and serum IFN-c concentration and
resulted in increased liver pathology in WT mice and overwhelming wasting disease in IL-17RA KO mice. Adoptively
transferred neutrophils were unable to migrate to tissues and to restore resistant phenotype in infected IL-17RA KO mice
but migrated to spleen and liver of infected WT mice and downregulated IFN-c production and increased survival in an IL-10
dependent manner. Our results underscore the role of IL-17RA in the modulation of IFN-c-mediated inflammatory responses
during infections and uncover a previously unrecognized regulatory mechanism that involves the IL-17RA-mediated
recruitment of suppressive IL-10-producing neutrophils.
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Introduction
The IL-17 cytokine family is formed by six members: IL-17A
(also called IL-17), IL-17B, IL-17C, IL-17D, IL-17E (also called
IL-25) and IL-17F [1]. The IL-17A and IL-17F are the best
characterized members of the IL-17 family. These cytokines share
the highest homology, are co-ordinately secreted by several subsets
of immune cells [2] and can exist either as IL-17A and IL-17F
homodimers or as IL-17A/IL-17F heterodimers [3]. Depending
on the target cell population (epithelial and endothelial cells,
fibroblasts, osteoblasts, and monocyte/macrophages), IL-17A and
IL-17F induce the secretion of colony-stimulating factors (e.g.,
GM-CSF and G-CSF), CXC chemokines (e.g., CXCL1, CXCL2
and CXCL8), metalloproteinases, mucins, and proinflammatory
cytokines (IL-6, IL-1 and TNF) [4]. Accordingly, IL-17A and IL-
17F orchestrate a potent inflammatory response involving
neutrophil recruitment and activation. In addition, these cytokines
cooperate with TLR ligands, IL-1b and TNF to enhance
inflammatory reactions and stimulate production of beta-defensins
and other antimicrobial peptides [5]. Given these proinflamma-
tory effects, production of IL-17A and IL-17F provides protection
against a wide array of pathogenic microorganisms but also plays
critical or contributing roles in several chronic inflammatory
diseases [6].
Biological roles of IL-17B, IL-17C and IL-17D are less clear.
IL-17B and IL-17C are able to stimulate the release of IL-1 and
TNF from a human monocytic cell line and cause neutrophil
infiltration [7,8], whereas IL-17D induces expression of IL-6, IL-8
and GM-CSF from entothelial cells [9]. Furthermore, transfer of
CD4+ T cells overexpressing IL-17B and IL-17C exacerbated
collagen-induced arthritis [10]. Altogether, these antecedents
suggest that IL-17B, IL-17C and IL-17D have similar activity to
induce inflammatory mediators, and contribute to inflammatory
responses like IL-17A and IL-17F [1]. In contrast, IL-17E has
been reported to ameliorate chronic inflammatory diseases by
suppressing Th1 and Th17 responses [11,12,13]. In addition, this
cytokine, secreted by T cells, eosinophils and epithelial and
endothelial cells, favors Th2 and Th9 responses and eosinophil
recruitment [14]. Consequently, IL-17E plays protective roles
against gastrointestinal helminth infections [15] but is deleterious
in allergic settings [16].
The IL-17 receptor (IL-17R) family includes five members (IL-
17RA to IL-17RE) that are thought to form homo or heterodimers
PLoS Pathogens | www.plospathogens.org 1 April 2012 | Volume 8 | Issue 4 | e1002658to give raise to functional receptors [17]. For example, the
receptor for IL-17A and IL-17F is a heterodimer formed by IL-
17RA and IL-17RC [18], while the heterodimer consisting of IL-
17RB and IL-17RA serves as receptor for IL-17E [19]. Recently,
IL-17RA has been shown to interact with IL-17RE to form the
signaling complex for IL-17C [20,21]. Thus, IL-17RA would
emerge as the common receptor chain for the IL-17 family
whereas the other subunit of the receptor would provide
specificity.
The protozoan parasite Trypanosoma cruzi is the causative agent
of Chagas’ disease, an endemic disease that affects 20 million
people in Central and South America. In the last years, cases are
more frequent in non-endemic areas in Europe and North
America as consequence of people migration. Host resistance
during experimental T. cruzi infection is dependent on both innate
and acquired cell-mediated immune responses requiring the
combined effects of many cell populations such as NK cells,
CD4+, and CD8+ T cells [22]. Also antibodies are important for
host survival and parasite clearance [23]. Concerning cytokines,
IFN-c plays a major protective role against T. cruzi infection by
activating macrophages to destroy ingested parasites and to release
proinflammatory cytokines [24,25,26]. Although required for
parasite clearance, increased Th1-type response and high levels
of IFN-c and TNF have been associated to the pathogenesis of
chronic Chagas disease [27,28,29,30]. Furthermore, models of
experimental T. cruzi infection using genetically-engineered mice
such as WSX-1(IL-27R) deficient mice showed that a dysregulated
proinflammatory cytokine production results in increased suscep-
tibility to this parasite infection [31]. Indeed, deficient signaling of
regulatory cytokines such as IL-10 correlated with increased
mortality during experimental T. cruzi infection due to over-
whelming inflammatory responses mediated by IFN-c and TNF
[32,33]. Altogether, the literature supports the notion that during
T. cruzi infection only a balanced production of inflammatory and
anti-inflammatory factors will allow the control of parasite
spreading without extensive collateral damage to the host.
The role of the IL-17 family during parasite infections is an
emerging area of research with often contradicting results. In this
regard, IL-17RA signaling has been shown to be both deleterious
and protective during Toxoplasma gondii infection [34,35]. Further-
more, two groups demonstrated that IL-17 plays a protective role
in T. cruzi infection [36,37], although the underlying mechanisms
remains poorly understood. Indeed, both reports showed signif-
icant contradictions that might be related to the different
experimental settings but deserves further investigation and
discussion.
In this report, we determined that the three most studied
members of the IL-17 family, IL-17A, IL-17E and IL-17F, are
produced during T. cruzi infection. Furthermore, we confirmed
that IL-17RA signaling is required for host resistance during the T.
cruzi infection and focused at the mechanisms underlying IL-
17RA-mediated protective effect. We determined that the
signaling through this receptor is essential to regulate exaggerated
Th1 inflammatory responses and the associated tissue damage by
recruiting regulatory IL-10-producing neutrophils. Our results
underscore the role of IL-17RA in the modulation of IFN-c-
mediated inflammatory responses during infections and uncover a
previously unrecognized regulatory mechanism that likely involves
IL-17 family-mediated recruitment of suppressive neutrophils.
Results
IL-17A, IL-17E and IL-17F are produced during T. cruzi
infection and IL-17RA expression is required for host
resistance
To evaluate the production of IL-17 cytokine family during the
course of T. cruzi infection, we first focused in the best
characterized inflammatory members IL-17A and IL-17F and
quantified these cytokines in plasma and culture supernatants of
cells obtained from C57BL/6 mice at different times post T. cruzi
infection. Production of IL-17A and IL-17F by cells from the
spleen and lymph nodes of infected mice peaked by days 10–20
post-infection and gradually decreased by day 32 post-infection
(Figure 1A). Although detectable, IL-17F production was about
1000 times lower than IL-17A. Indeed, IL-17F was not
quantifiable in plasma while IL-17A was detectable, but only
during a short period around day 20 post T. cruzi infection
(Figure 1B and data not shown). Moreover, in acutely infected
mice IL-17A+ leukocytes were identified by flow cytometry in
target organs such as the liver (Figure 1C). The IL-17A+ cells
present in spleen, lymph nodes and liver of T. cruzi infected mice
comprised both CD3+ as well as CD32 cells (Figure 1D). To
further identify the cell sources of IL-17A during T. cruzi
infection, different populations were sorted from spleen and liver
of infected mice according to the expression of NK1.1, CD3,
CD4, CD8 and Gr-1. Secretion of IL-17A was detected in the
culture supernatants of NK cells, CD4+ and CD8+ T cells as well
as Gr-1 (likely neutrophils) cells (Figure 1E). Furthermore, other
populations were also able to secrete this cytokine as IL-17A
production was detected in the culture supernatants of the
negative fraction. Further experiments indicated that the other
IL-17-producing populations comprised cd T cells that have been
reported as an important innate source of IL-17 in many
infections [38] as well as another cell subset not previously
described as IL-17 producer, which is matter of current research
(data not shown). Next, we evaluated concentration of IL-17E,
the member of the IL-17 family typified as anti-inflammatory
cytokine. In contrast to IL-17A and IL-17F, IL-17E was readily
detectable in the plasma of non-infected mice but its concentra-
tion was increased twice in the plasma of 20-day infected mice
indicating that IL-17E was also induced during T. cruzi infection
(Figure 1F).
Author Summary
IL-17 family is comprised for six members (IL-17A to F) that
have been reported to play protective effects in bacterial
and fungal infections and contradictory roles in parasite
infections. Using mice deficient in IL-17RA, the common
receptor subunit for many IL-17 family members, we
determined that these cytokines are required for host
protection against the parasite Trypanosoma cruzi.I n
absence of IL-17 signaling, mice developed an aggravated
infection with similar levels of parasite in blood but
increased inflammation and tissue damage of vital organs
such as liver. We evaluated the mechanisms underlying
this increased susceptibility and determined that the
absence of IL-17RA caused a reduced arrival of neutrophils
to organs such as spleen and liver. Neutrophils are
phagocytic cells with abilities to directly destroy patho-
gens and also to regulate the inflammatory response.
Indeed, we determined that neutrophils from T. cruzi
infected mice are poisoned to secrete the regulatory
cytokine IL-10. Finally, by experiments of depletion and
adoptive transfer of neutrophils we determined that,
during T. cruzi infection, IL-17RA is required for the
recruitment of neutrophils that destroy the parasite and
that also regulate inflammatory responses and collateral
tissue damage by secreting IL-10.
IL-17RA Favors Regulatory Neutrophil Recruitment
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17RA KO mice were infected with T. cruzi and the progression of
the infection was evaluated in comparison to wild-type (WT) mice.
As illustrated in Figure 2A, IL-17RA KO mice showed increased
mortality during T. cruzi infection. Because mortality during acute
T. cruzi infection is often consequence of the combination between
Figure 1. IL-17A, IL-17E and IL-17F production during T. cruzi infection. A) IL-17A and IL-17F concentration determined in the culture
supernatants of spleen and lymph node cells obtained from mice at different times post T. cruzi infection and stimulated during 48 h in the presence
of CD3/PdBU. Data are shown as mean 6 SD, n=5 mice per group. B) Plasma IL-17A concentration in non-infected (NI) or 20-day T. cruzi-infected (I)
mice. Data are shown as mean 6 SD, n=5 mice per group. C) Percentage of IL-17A positive cells after 5 h PMA/Ionomycin stimulation of liver cell
suspensions obtained from 20-day T. cruzi-infected mice. Plot representative of one out of five mice. D) Percentage of IL-17A positive cells within CD3
positive and CD3 negative cell population after 5 h PMA/Ionomycin stimulation of spleen, lymph nodes and liver cells from 20-day T. cruzi-infected
mice. Data are shown as mean 6 SEM, n=5 mice per group. E) IL-17A concentration determined in the culture supernatants of NK1.1+ cells, CD4+
and CD8+ T cells, Gr-1+ cells and the remaining negative fraction (NF) sorted from the spleen and liver of 20-day T. cruzi infected mice and stimulated
during 48 h. Data are shown as mean 6 SD of triplicates cultures. F) Plasma IL-17E concentration in non-infected (NI) or 20-day T. cruzi-infected (I)
mice. Data are shown as mean 6 SD, n=5 mice per group. Data in A, E and F and in B–D are representative of two and three independent
experiments, respectively.
doi:10.1371/journal.ppat.1002658.g001
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PLoS Pathogens | www.plospathogens.org 3 April 2012 | Volume 8 | Issue 4 | e1002658Figure 2. Increased mortality, tissue parasitism and hepatic damage in IL-17RA KO mice during T. cruzi infection. A) Survival of WT and
IL-17RA KO mice after T. cruzi infection, P value calculated with a Gehan-Breslow-Wilcoxon test, n=20 per group. B) Parasitemia determined at
different time post T. cruzi infection in WT and IL-17RA KO mice, n=10 per group. P values calculated using two-tailed T test. C) Plasma activity of ALT
and AST in WT and IL-17RA KO mice at different times post T. cruzi infection. Data are shown as mean 6 SD, n=5 mice per group. P values calculated
using two-way ANOVA followed by Bonferroni’s posttest. D) Photographs of Hematoxilin/Eosin stained liver sections from 20-day T. cruzi infected WT
and IL-17RA KO mice. 2006micrographs allow panoramic evaluation of the lesions. An extensive necrotic area is demarcated in the liver from KO
mice. 10006 micrograph show details about the cellular alterations and the nature of inflammatory infiltrate (P: polymorphonuclear cells, M:
mononuclear cells, A: amastigote nest). Photographs are representative of one out of five mice. Data in A–C and in D are representative of three and
two independent experiments, respectively.
doi:10.1371/journal.ppat.1002658.g002
IL-17RA Favors Regulatory Neutrophil Recruitment
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organs; we evaluated these aspects in IL-17RA KO versus WT
mice. We first determined that T. cruzi-infected IL-17RA KO mice
showed similar parasitemia than WT controls (Figure 2B). To
evaluate organ damage we focused in the liver and determined the
plasma activity of the liver transaminases AST and ALT
(Figure 2C). After 20 days of T. cruzi infection, increased AST
and ALT activity were detected in WT and IL-17RA KO mice;
however, the KO group presented significantly higher activity of
the liver transaminases in plasma, suggesting increased liver
damage. Histological analysis of the liver from acutely infected
mice corroborated important evidences of liver injury in both WT
and IL-17RA KO mice (Figures 2D and S1 in Text S1). Cellular
infiltrate was already prominent by day 10 post-infection,
augmented during the peak of the infection (day 18) and declined
afterwards. Evidence of important cellular alterations was found
during the peak of infection (day 18–20) and at later time points
(day 32 post-infection). General hepatic structure was conserved
but hepatocytes were round and swollen and showed vacuolar
cytoplasm and picnotic nuclei. Kupffer’s cell showed important
hyperplasia. Focal necrosis and hyaline degeneration were
observed in areas of varied extension depending on the group of
mice evaluated. Of note, throughout the time course study and for
all the evaluated parameters, but particularly in the extension of
necrosis and hyaline degeneration, infected IL-17RA KO mice
showed more severe lesions in comparison to WT mice (Table 1,
Figure 2D and Figure S1 in Text S1). In addition, the
predominant cell type present in the inflammatory infiltrates was
clearly different between infected WT mice that showed
neutrophilic infiltrate and infected IL-17RA KO mice that
presented monocytic/lymphocytic infiltrate (Figure 2D and
Table 1).
Increased IFN-c production in T. cruzi-infected IL-17RA
KO mice correlates with hepatic damage and mortality
Because dysregulated inflammatory responses can contribute to
organ damage and mortality during T. cruzi infection, we
evaluated the levels of proinflammatory cytokines such as IFN-c
and TNF in the serum of T. cruzi infected WT and IL-17RA KO
mice. At day 20 post-infection, plasma levels of both cytokines
were significantly higher in IL-17RA KO mice than in WT mice
(Figure 3A). Accordingly, 20-day infected IL-17RA KO mice
showed increased percentage of IFN-c+ T cells in spleen and liver
in comparison to WT control (Figure S2A in Text S1). Moreover,
spleen CD4+ and liver CD8+ T cells and spleen and liver CD8+ T
cells from infected IL-17RA KO mice secreted more IFN-c and
TNF, respectively, than WT counterparts (Figure S2B in Text S1).
To address the role of the augmented IFN-c response in the
increased susceptibility of IL-17RA KO mice to T. cruzi,w e
evaluated the progression of the infection in mice receiving a IFN-
c blocking treatment. Injection of neutralizing anti-IFN-c
monoclonal antibodies (Abs) greatly reduced plasma IFN-c
concentration in T. cruzi infected WT and IL-17RA KO mice
(Figure 3B). As expected due to the role of this cytokine in parasite
control, IFN-c blockade during T. cruzi infection resulted in higher
parasitemia in WT and IL-17RA KO mice after 20 days post-
infection (Figure 3C). In contrast, the plasma activity of the hepatic
transaminases ALT and AST as well as histopathological damage
of the liver were significantly diminished in infected IL-17RA KO
but not in infected WT mice after the anti-IFN-c treatment
(Figure 3D and Table 2). Overall, the blocking treatment did not
affect the survival of infected WT mice but increased survival of
infected IL-17RA KO mice to levels comparable to the WT
control group (Figure 3E).
Neutrophil recruitment is reduced in T. cruzi infected IL-
17RA KO mice
We next sought to determine whether the dysregulated IFN-c
response observed in infected IL-17RA KO mice correlated with
an altered expansion or distribution of immune cell populations in
secondary lymphoid or target organs. To this end, we first
compared the total cell numbers in spleen, lymph nodes and liver
from infected WT and IL-17RA KO mice. During the course of
the infection, both group of mice presented similar cell numbers in
secondary lymphoid organs, but infected IL-17RA KO mice
showed a reduced number of infiltrating cells in liver (Figure 4A).
In particular, we found that, in comparison to WT controls, T.
cruzi infected IL-17RA KO mice presented a significant reduction
in the frequency and absolute numbers of a CD11b+Gr-1+cell
population in spleen and liver (Figure 4B and 4C). Evaluation of
the expression of several surface markers in the CD11b+Gr-1+
population showed a pattern compatible with neutrophils (i.e. Ly-
6G
high; Ly-6C+ and F4/802 with variable expression of CD11c
according to the organ source) (Figure S3A in Text S1).
Neutrophil morphology was confirmed by optic microscopy
(Figure S3B in Text S1).
Reduced neutrophil numbers in spleen and liver of T. cruzi
infected IL-17RA KO mice was unlikely consequence of a
deficient myelopoiesis because, similar to infected WT animals,
these mice presented increased percentages and absolute numbers
of neutrophils in bone marrow and blood in comparison to non-
infected controls (Figures S4A and B in Text S1). Accordingly, T.
cruzi infected IL-17RA KO and WT mice showed no differences in
the concentration of the neutrophil growth factor G-CSF in spleen
Table 1. Time course study of hepatic lesions in T. cruzi infected WT and IL-17RA KO mice.
Group (n=5) Day post-infection Inflammatory infiltrate




WT 10 +++ (PMN) ++
18 ++++ (PMN) ++ +
32 +++ (PMN) ++ +
KO 10 ++ (Mo/Ly) ++ +
18 +++ (Mo/Ly) ++/+++ +++
32 ++ (Mo/Ly) ++/+++ +++
aScale: +: mild; ++:moderate; +++: severe; ++++: extremely severe.
bPMN: Polymorphonuclear cells; Mo/Ly: monocyte/lymphocytes.
doi:10.1371/journal.ppat.1002658.t001
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production of chemokines such as CXCL1 (KC) and CXCL2
(MIP-2), known to act as neutrophil chemoattractants [39,40] and
to be modulated by the IL-17 family [41]. We determined that
both chemokines were clearly induced by T. cruzi infection in the
spleen and liver of WT mice but, throughout the infection period
evaluated or at least during the peak of the infection (day 20 post-
infection), showed reduced concentration in the same tissues from
IL-17RA KO mice (Figure 4D). In contrast, the concentration of
CXCL-10 (IP-10), a chemokine induced by IFN-c [42], showed a
tendency to be higher in the spleen and liver of T. cruzi infected IL-
17RA KO mice in comparison to WT controls although the
Figure 3. Augmented production of IFN-c caused increased hepatic damage and mortality in T. cruzi infected IL-17RA KO mice. A)
Plasma IFN-c and TNF concentration in 20-day T. cruzi infected WT and IL-17RA KO mice. Data are shown as mean 6 SD, n=6 mice per group. P
values calculated using two-tailed T test. B) Plasma IFN-c concentration in 20-day T. cruzi infected WT and IL-17RA KO mice treated with anti-IFN-c.P
values calculated using two-tailed T test. C) Parasitemia determined in 20-day T. cruzi infected WT and IL-17RA KO mice treated with anti-IFN-c. Data
are shown as mean 6 SD, n=6 mice per group. P values calculated using two-tailed T test. D) Activity of ALT and AST determined in the plasma of 20-
day T. cruzi infected WT and IL-17RA KO mice treated with anti-IFN-c. Data are shown as mean 6 SD, n=6 mice per group. P values calculated using
two-tailed T test. E) Survival of T. cruzi infected WT and IL-17RA KO mice treated with anti-IFN-c. P value calculated with a Gehan-Breslow-Wilcoxon
test, n=12 per group. Data in A and in B–E are representative of four and two independent experiments, respectively.
doi:10.1371/journal.ppat.1002658.g003
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post-infection (Figure 4D). Altogether these results suggested that
the absence of IL-17RA signaling during T. cruzi infection affected
the recruitment rather than the development or survival of
neutrophils. Similar impairment in neutrophil recruitment was
reported in other experimental infections using mice deficient for
IL-17 signaling [35,43].
To confirm the impairment in neutrophil recruitment, we
injected dye-stained neutrophils purified from bone marrow of
WT and IL-17RA KO mice and evaluated their distribution/
migration in infected and non-infected mice (Figure 4E). Three
hours after intravenous injection, neutrophils were mainly present
in the bone marrow of non-infected WT and IL-17RA KO mice.
The distribution of the injected cells was different in T. cruzi
infected mice with low number of the transferred neutrophils
detected in the bone marrow and preferential presence in blood
and organs. Thus, infected WT and IL-17RA KO mice presented
similar numbers of the injected Ly-6G+ neutrophils in the blood
and bone marrow. Furthermore, injected neutrophils were
recruited into the spleen and liver of infected WT mice,
independently on the expression of IL-17RA on the injected
neutrophils themselves. In contrast, but in concordance with their
lower production of CXCL1/CXCL2, significantly lesser numbers
of the injected neutrophils reached spleen and liver of infected IL-
17RA KO mice compared to infected WT controls. These results
confirmed that lack of IL-17RA in host cells, but not in the
migrating neutrophils themselves, were required for proper
neutrophil recruitment into tissues during T. cruzi infection.
T. cruzi infection promotes the differentiation of IL-10
producing neutrophils that show suppressive function in
vitro
Besides their innate role as phagocytes, neutrophils interact with
other immune cells and secrete cytokines able to regulate adaptive
cellular immune responses [44]. To elucidate whether reduced
neutrophil recruitment during T. cruzi infection may affect not
only direct parasite control but also IFN-c secretion, we analyzed
neutrophil cytokine production in our experimental settings.
Neutrophils purified from bone marrow of non-infected WT and
IL-17RA KO mice and cultured with live T. cruzi tripomastigotes
secreted IL-10 and TNF, but minimal or no IL-1b, IL-6 and IL-
12p70 (Figure 5A, Figure S5 in Text S1 and data not shown).
Furthermore, CD11b+Ly-6G+ neutrophils sorted from the spleen
of T. cruzi infected WT and IL-17RA KO mice and stimulated
with live T. cruzi produced higher levels of IL-10 and similar levels
of TNF compared to Pam3CSK4 stimulated neutrophils
(Figure 5B). To evaluate the possible regulatory effect of IL-10-
secreting neutrophils, we performed a typical in vitro suppression
experiment determining cell proliferation and cytokine production
of CFSE-labeled splenocytes activated with anti-CD3 and anti-
CD28 in the presence or absence of neutrophils. CD3+
splenocytes cultured in the presence of spleen neutrophils sorted
from infected WT and IL-17RA KO mice showed reduced
proliferation and frequency of IFN-c producing cells. Blockade of
IL-10R in these co-cultures restored CD3+ splenocyte prolifera-
tion and IFN-c production (Figure 5C).
Neutrophils regulates IFN-c production and hepatic
damage in vivo during T. cruzi infection
To understand the in vivo biological relevance for T. cruzi
infection of the reduced neutrophil numbers observed in the liver
and spleen of IL-17RA KO mice, we performed neutrophil
depletion experiments using an anti-Ly-6G specific monoclonal
Ab. Our injection scheme completely depleted CD11b+Ly-6G+
neutrophils from blood of T. cruzi infected WT and IL-17RA KO
mice and reduced the number of these cells in organs such as
spleen and liver (Figure 6A). Neutrophil depletion significantly
reduced IL-10 secretion by spleen and liver cell suspensions from
20-day infected WT and IL-17RA KO mice (Figure 6B),
indicating that these cells are an important source of IL-10 during
the acute phase of T. cruzi infection. Likely as a consequence of the
reduced IL-10 levels, anti-Ly-6G treatment raised the plasma
concentration of IFN-c and TNF in T. cruzi infected WT and IL-
17RA KO mice (Figure 6C). Of note, the increased levels of type 1
proinflammatory cytokines observed in both neutrophil-depleted
groups of mice correlated with increased liver damage as
determined by the significant augment in the plasma activity of
hepatic transaminases (Figure 6D). Regarding parasitemia, the
anti-Ly-6G treatment had opposite outcomes according to the
group of mice and resulted in lower and higher blood parasite
numbers in infected WT and IL-17R KO mice, respectively
(Figure 6E). This discrepant result would reflect how differently an
enhanced IFN-c mediated inflammatory response affected infec-
tion progression in each group of mice. Thus, increased IFN-c
levels in neutrophil depleted WT mice favored liver damage but
also facilitated parasite control. In contrast, even higher levels of
inflammatory cytokines in anti-Ly-6G treated IL-17RA KO mice
induced devastating tissue damage that likely lead to the inability
to control parasite replication. Indeed, neutrophil depletion
significantly augmented mortality and wasting disease in infected
IL-17R KO mice and showed a tendency to reduce survival in
infected WT mice although it was not statistically significant when
compared to the control group (Figure 6F).
As a second approach to evaluate the role of neutrophil during
the course of T. cruzi infection, we performed adoptive transfer
experiments with a scheme involving four injections of WT
neutrophils at different times post-infection. Neutrophil adoptive
transfer resulted in a significant drop in the parasitemia levels in
both infected WT and IL-17RA KO mice (Figure 7A). This would
reflect the ability of the injected neutrophils to directly kill
Table 2. Hepatic lesions in anti-IFN-c treated T. cruzi infected WT and IL-17RA KO mice at day 20 post-infection.
Group (n=5) Inflammatory infiltrate




WT Control +++ (PMN) ++ +++
WT anti-IFN-c ++++ (PMN) +++ +++
KO Control ++/+++ (Mo/Ly) ++++ ++++
KO anti-IFN-c +++ (Mo/Ly) + +++
aScale: +: mild; ++:moderate; +++: severe; ++++: extremely severe.
bPMN: Polymorphonuclear cells; Mo/Ly: monocyte/lymphocytes.
doi:10.1371/journal.ppat.1002658.t002
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contrast, and likely as consequence of differences in the tissue
distribution of the transferred neutrophils between infected WT
and IL-17RA KO mice (Figure 4E), neutrophil injection
diminished plasma IFN-c concentration only in infected WT
mice (Figure 7B). In correlation with the combined reduction in
blood parasite numbers and proinflammatory IFN-c production,
neutrophil-injected infected WT but not IL-17RA KO mice
showed increased survival in comparison to controls (Figure 7C).
To further elucidate the role of the IL-10 produced by the injected
neutrophils in the regulation of IFN-c production, we repeated the
adoptive transfer experiment with neutrophils purified from WT
and IL-10-deficient mice using infected WT mice as recipients.
Lack of IL-10 production by the injected neutrophils did not affect
their ability to reduce blood parasite numbers (Figure 7D) but, in
agreement with our in vitro results (Figure 5C), significantly
impaired their capacity to decreased plasma IFN-c concentration
(Figure 7E). Furthermore, in contrast to WT neutrophils, adoptive
transfer of IL-10 deficient neutrophils failed to reduce the
mortality of the infected WT recipient (Figure 7F).
Discussion
Several members of the IL-17 family have been reported to
have protective roles in host resistance against different microbes
[1]. Such a role for IL-17A, the founding member of this family,
as well as for IL-17F during bacterial and fungal infections has
been largely recognized [45]. Furthermore, IL-17C has been
recently shown to trigger similar effector responses than IL-17A
and to participate in the immunity against certain intestinal
bacteria [21]. Also IL-17E contributes to host resistance against
gut microorganisms leading to the control of helminth infections
by inducing Th2 responses [46]. Although increasing evidence
supports a protective role for IL-17 family in extracellular
infections, its function during infections with intracellular
microorganisms where Th1 are required for host resistance
remains less clear. Particularly during T. cruzi infection, IL-17A
was reported to play a protective role by two independent groups
[36,37]; however, both reports showed important contradictions
and the underlying mechanisms remained unresolved. Moreover,
both studies used different experimental approaches that targeted
IL-17A but not other IL-17 cytokines such as IL-17F and IL-17C
that would have similar effector functions and could compensate
for the lack of IL-17A. Indeed, we determined that during T. cruzi
infection not only IL-17A but also IL-17E and IL-17F are
produced during the peak of the infection. Whether other
cytokines of the IL-17 family are induced by T. cruzi infection and
the signals involved in their induction as well as the identity of
cytokine-producing cell subsets are matter of current research in
our laboratory.
Using IL-17RA deficient mice allowed us to understand the
contribution of the IL-17 family to host resistance during T. cruzi
infection overcoming the possible redundant function of some of
its members. Indeed, our results differ in some aspects with those
of Miyazaki et al that used IL-17A KO mice that specifically lacked
IL-17A but had conserved signaling for the other members of the
family. In contrast, our findings are more similar to those of da
Matta Guedes et al that used a blocking Ab to neutralize IL-17A
that could be crossreacting with other members highly homolo-
gous to IL-17A such as IL-17F, inhibiting all their functions. In
this context, we determined that the absence of IL-17RA
expression lead to increased mortality during the acute phase of
T. cruzi infection. Increased mortality was not associated to
augmented parasitemia but rather correlated with an exaggerated
inflammatory response that severely affected liver and likely other
vital organs such as heart and kidneys as described for IL-172/2
mice [37]. Indeed, we formally demonstrated that the susceptible
phenotype of IL-17RA KO mice to T. cruzi infection was, at least
in part, a consequence of a dysregulated inflammatory response
caused by an exacerbated production of type 1 inflammatory
cytokines such as IFN-c and TNF production. Thus, IFN-c
blockade in T. cruzi infected IL-17RA KO mice mimicked the
more resistant phenotype (increased survival and moderate liver
damage) observed in WT mice.
From the cytokines that signals through IL-17RA, the
proinflammatory IL-17A was surprisingly reported to suppress
pathological IFN-c dependent inflammation preventing tissue
destruction [47]. Thus, in a model of graft-versus-host disease, IL-
17A deficiency elicited an amplified Th1 response with high IFN-c
levels and greater severity of the disease [48]. Furthermore, IL-
17A prevented and IL-17F exacerbated IFN-c production and
tissue destruction in a dextran sodium sulfate colitis model [49].
Also IL-17E, early classified as an anti-inflammatory cytokine, is
able to inhibit IFN-c as well as IL-17 production during infections
and autoimmune settings [50]. A contrasting scenario was
depicted for the last cytokine described to use IL-17RA as
receptor complex, as the few available studies point at a
proinflammatory role for IL-17C through the induction of IL-
17A but not IFN-c [20]. Thus, considering the available literature,
it is likely that the phenotype of exuberant IFN-c production,
tissue damage and mortality observed in T. cruzi infected IL-17RA
deficient mice could be attributed to the lack of response to not
only IL-17A and IL-17F but also IL-17E. Furthermore, we cannot
rule out that also the lack of response to IL-17C may somehow
contribute to the susceptible phenotype of IL-17RA KO mice
during T. cruzi infection. Further studies using mice deficient for
individual or combined cytokines will be required to understand
the specific contribution of each IL-17 family member.
Besides the exacerbated type 1 inflammatory responses, lack of
IL-17RA expression during T. cruzi infection resulted in decreased
neutrophil numbers in organs such as spleen and liver that
kinetically correlated with impaired production of the neutrophil
chemoattractants CXCL1 and CXCL2 in those peripheral tissues.
Figure 4. Reduced neutrophil chemoattractant production and neutrophil recruitment in the spleen and liver of T. cruzi infected IL-
17RA KO mice. A) Cell numbers in spleen, lymph nodes and liver of WT and IL-17RA KO mice determined at different times after T. cruzi infection.
Data are shown as mean 6 SD, n=5 mice per group. P values calculated using two-way ANOVA followed by Bonferroni’s posttest. B) Percentage of
CD11b+ Gr-1+ neutrophils in spleen and liver of 20-day T. cruzi infected WT and IL-17RA KO mice. Plots are representative one out of five mice. C)
Absolute numbers of CD11b+ Gr-1+ neutrophils in spleen (left) and liver (right) of 20-day T. cruzi infected WT and IL-17RA KO mice. Each symbol
represents a different mouse and horizontal line indicates the mean. P values calculated with two-tailed T test. D) Concentration of CXCL1, CXCL2 and
CXCL10 in spleen and liver homogenates obtained from WT and IL-17RA KO mice at different times post T. cruzi infection. Data are shown as mean 6
SD of biological triplicates, normalized to total protein concentration, n=5 mice per group. P values calculated with two-way ANOVA followed by
Bonferroni’s posttest. (* p: spleen WT vs spleen KO; # p: liver WT vs liver KO). E) Absolute number or frequency of transferred WT and IL-17RA KO
neutrophils detected in bone marrow, blood, spleen and liver of non-infected (NI) and infected (I) WT and IL-17RA KO mice 3 h after i.v. injection.
Data are shown as mean 6 SD, n=5 per group. P values calculated with two-tailed T test. Data in A–C and D–E are representative of four and two
independent experiments, respectively.
doi:10.1371/journal.ppat.1002658.g004
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may not be affected by IL-17 family and could account for the few
neutrophils present in infected IL-17RA KO mice, the reduction
in CXCL1/CXCL2 has been proved to greatly affect neutrophil
recruitment into tissues in many inflammatory conditions [51] and
likely explains the deficient neutrophil migration in infected IL-
17RA KO mice. These results focused our work at investigating
the relationship that linked the IL-17RA-induced neutrophil
recruitment with the inflammation during T. cruzi infection.
Neutrophils were previously reported to play either protective or
deleterious roles during Chagas’ disease according to the mice
strain [52]. However, this conclusion was based in the depletion of
Figure 5. Suppression of T cell proliferation and IFN-c production by IL-10 secreting neutrophils obtained from T. cruzi infected
mice. A–B) Concentration of IL-10 and TNF determined in 48 h culture supernatants of Ly-6G+ neutrophils purified from bone marrow of WT and IL-
17RA KO mice (A) and of CD11b+Ly-6G+ neutrophils sorted from spleen 20-day T. cruzi infected WT and IL-17RA KO mice (B) and stimulated as
indicated. Data are shown as mean 6 SD of cuatriplicates. C) Proliferation and percentage of IFN-c-producing CD3 positive splenocytes from normal
mice after 5 day stimulation in anti-CD3 and anti-CD28 coated plates in the presence of CD11b+Ly-6G+ neutrophils obtained from 20-day T. cruzi
infected WT and IL-17RA KO mice and of a blocking anti-IL10R Ab. Data are shown as mean 6 SD of triplicates. P values calculated using two-tailed T
test. Data in A–C are representative of two independent experiments.
doi:10.1371/journal.ppat.1002658.g005
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but also dendritic cells, monocytes, macrophages and lymphocytes
and therefore, the reported effects cannot be solely ascribed to
neutrophils [53]. Consequently, the specific role of neutrophils
during T. cruzi infection remained elusive and should be
reevaluated using newly available and highly specific tools such
as the specific Ly-6G (1A8) mAbs.
Even though neutrophils were historically regarded as strict
innate cells characterized by unspecific killing abilities and
proinflammatory properties, accumulating data suggest that these
cells express a vast array of pattern recognition receptors and
respond to environmental cues producing several cytokines and
chemokines that modulate innate and adaptive immunity [44].
Indeed, the crosstalk between neutrophils and T cells has been
Figure 6. Increased IFN-c production and hepatic transaminases activity in T. cruzi infected WT and IL-17RA KO mice after
neutrophil depletion. A) CD11b+Gr-1+ frequency and absolute numbers in blood, spleen and liver of 20-day T. cruzi infected WT and IL-17RA KO
mice treated with anti-Ly6G mAbs. Data are shown as mean 6 SD, n=6–8 mice per group. P values calculated by two-tailed T test. B) Concentration
of IL-10 determined in 48 h unstimulated culture supernatants of spleen and liver cell suspensions obtained from 20-day T. cruzi infected WT and IL-
17RA KO mice treated with anti-Ly-6G mAbs. Each symbol represents a different mouse and horizontal line indicates the mean. P values calculated
with two-tailed T test. C) Plasma IFN-c and TNF concentration in 20-day T. cruzi infected WT and IL-17RA KO mice treated with anti-Ly-6G mAbs. Each
symbol represents a different mouse and horizontal line indicates the mean. P values calculated with two-tailed T test. D) Activity of ALT and AST
determined in the plasma of 20-day T. cruzi infected WT and IL-17RA KO mice treated with anti-Ly-6G. Data are shown as mean 6 SD, n=6–8 mice
per group. P values calculated using two-tailed T test. E) Parasitemia determined in 20-day T. cruzi infected WT and IL-17RA KO mice treated with anti-
Ly-6G Abs. Data are shown as mean 6 SD, n=6–8 mice per group. P values calculated using two-tailed T test. F) Survival of T. cruzi infected WT and
IL-17RA KO mice treated with anti-Ly-6G. P value calculated with a Gehan-Breslow-Wilcoxon test, n=12 per group. Data in A–D and in E are
representative of three and two independent experiments, respectively.
doi:10.1371/journal.ppat.1002658.g006
Figure 7. IL-10-dependent modulation of IFN-c production by adoptively transferred neutrophils during T. cruzi infection. A)
Parasitemia determined at day 20 post-infection in infected WT and IL-17RA KO mice adoptively transferred with WT neutrophils. Data are shown as
mean 6 SD, n=6 per group. P values calculated with two-tailed T test. B) Concentration of IFN-c in plasma of 20-day T. cruzi infected WT and IL-17R
KO mice adoptively transferred with WT neutrophils. Data are shown as mean 6 SD, n=6 per group. P values calculated with two-tailed T test. C)
Survival of T. cruzi infected WT and IL-17R KO mice adoptively transferred with WT neutrophils. P value calculated with a Gehan-Breslow-Wilcoxon
test, n=12 per group. D) Parasitemia determined at day 20 postinfection in infected WT mice adoptively transferred with WT and IL-10 KO
neutrophils. Data are shown as mean 6 SD, n=12 per group. P values calculated with two-tailed T test. E) Concentration of IFN-c in plasma of 20-day
T. cruzi infected WT mice adoptively transferred with WT and IL-10 KO neutrophils. Data are shown as mean 6 SD, n=12 per group. P values
calculated with two-tailed T test. F) Survival of T. cruzi infected WT mice adoptively transferred with WT and IL-10 KO neutrophils. P value calculated
with a Gehan-Breslow-Wilcoxon test, n=12 per group. Data in A–F are representative of two independent experiments.
doi:10.1371/journal.ppat.1002658.g007
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including acute and chronic inflammation during infections and
cancer [54]. Noteworthy, adoptive transfer experiments as well as
specific Ly-6G+ neutrophil depletion allowed us to uncover the
critical and unexpected role of neutrophil in the regulation of type
1 inflammatory response and tissue damage during T. cruzi
infection. Thus, repetitive adoptive transfer of neutrophils during
T. cruzi infection resulted in lower parasitemia in both WT and IL-
17RA KO mice and in reduced IFN-c production only in WT
mice. These findings may reflect that neutrophils could be directly
involved in the killing or phagocytosis of circulating T. cruzi as
reported for blood-stage plasmodium [55]. Therefore, presence of
additional neutrophils in the blood of WT and IL-17RA KO mice
may help to lower the parasitemia in a mechanism rather
independent on migration into tissues or IFN-c levels. In contrast,
neutrophil regulation of the adaptive response (i.e. downregulation
of IFN-c production) was restricted to WT mice as it would
require the IL-17-dependent recruitment of the injected neutro-
phil to immune induction or effector sites. Interestingly, the
reduction of parasitemia levels after neutrophil transfer was not
enough to prevent mortality as neutrophil-injected IL-17RA KO
mice showed the same mortality than the control KO group. In
contrast, the decrease of the IFN-c levels and the associated
inflammatory liver damage together the lower parasitemia would
account for the increased survival of infected WT mice injected
with neutrophils.
In the same direction, an anti-Ly6G treatment resulted in the
amplification of IFN-c and TNF production in infected WT and
IL-17R KO mice likely as consequence of reduced production of
the regulatory cytokine IL-10 after neutrophil depletion. The
augmented type 1 inflammatory response in infected WT mice
correlated with increased plasma levels of the hepatic transami-
nases but also with reduced parasitemia and, in overall, did not
significantly affect survival. Thus, although anti-Ly6G-treated
infected WT mice resembled infected IL-17RA KO mice in some
aspects such as exuberant IFN-c and TNF production and
enhanced liver damage, they did not show the same high mortality
rate. There are several possible and not mutually exclusive causes
for such difference. One possible explanation is that additional
mechanisms besides the reduced neutrophil numbers are involved
in the exacerbated inflammatory response and reduced resistance
to T. cruzi infection of IL-17RA KO mice. In this regard, we are
evaluating the possible contribution of IL-17E in the recruitment
of eosinophils and the suppression inflammatory responses.
Moreover, T-cell intrinsic effect are not ruled out and as suggested
in a colitis model [49], lack of IL-17RA signaling may release IL-
17 mediated suppression of T-bet expression facilitating an
aberrant Th1 differentiation program independent on other
extrinsic signals. In addition, IL-17A has been reported to be
required for the development of cytotoxic and humoral responses
[56,57], therefore parasite-specific adaptive immune responses
may be undermined in T. cruzi infected mice lacking IL-17RA
signaling contributing to reduced resistance to infection. Finally,
another possible explanation is that the few neutrophils that
remained in tissues of anti-Ly6G-treated WT infected mice may
be able to partially contain overwhelming inflammation and organ
injury. In this regard, the depleting treatment in infected IL-17RA
KO mice that per se presented reduced tissue neutrophil numbers
further exacerbated the already exuberant IFN-c and TNF
secretion and worsened liver damage, resulting in wasting disease,
higher parasitemia and increased mortality. Altogether, these
results support the notion that during T. cruzi infection, besides
their innate function in parasite control, neutrophils play a
regulatory role on the adaptive immune response with beneficial
and detrimental effects in host resistance. Of note, during T. cruzi
infection Foxp3+ regulatory T cells have been reported to play
limited or even irrelevant roles [58,59]. Therefore, in a context
where the main regulatory cell subset showed reduced relevance,
other cell populations with some regulatory abilities (i.e.
neutrophils, regulatory B cells, M2 macrophages, etc) may take
over the regulatory stage.
The suppressive role of neutrophils has been recognized in the
recent years, mainly through the description of myeloid suppressor
cells [60]. In addition, two recent reports described the existence of
suppressor IL-10-producing neutrophils during a bacterial infec-
tion and melanoma [61,62]. Furthermore, a recent work using IL-
10-b-lactamase reporter mouse revealed that neutrophils are the
major source of IL-10 during systemic Yersinia enterocolitica infection
[63]. In this context, we demonstrated that bone marrow
neutrophils stimulated with live T. cruzi produced IL-10 as well
as TNF but not other proinflammatory cytokines. Furthermore,
spleen neutrophils purified from infected mice produced high
levels of IL-10 and low levels of TNF after restimulation with the
parasite suggesting that T. cruzi infection somehow poisoned a
‘‘regulatory’’ status in these cells. Remarkably, neutrophils purified
from the spleen of T. cruzi infected mice showed a suppressor
function as they inhibited T cell proliferation and IFN-c
production in an IL-10R-dependent manner. Dependency on
IL-10 for the suppressive effect of neutrophils was corroborated in
vivo as adoptive transfer of IL-10 deficient neutrophils into infected
WT recipient failed to dowregulate IFN-c production and to
increase survival although they significantly controlled blood
parasite numbers. Again, this result highlights that the solely
reduction in parasitemia is not enough to prevent mortality in
conditions of important tissue damage. Of note, IL-17RA deficient
neutrophils produced similar amounts of IL-10 and, accordingly,
showed the same suppressor ability than WT counterparts in vitro,
suggesting that IL-17RA signaling in the neutrophils themselves is
not required for the acquisition of the ‘‘regulatory’’ phenotype or
migration into tissues. Toll-like receptor ligands [61] as well as the
acute-phase reactant serum amyloid A [62] have been shown to
promote differentiation of IL-10 producing neutrophils. As the T.
cruzi bear several TLR-2 and -4 ligands [64] and promote serum
amyloid A production by macrophages [65], it is likely that during
this parasite infection both signals cooperate to induce a proper
environment for the induction of suppressor IL-10 producing
neutrophils.
Altogether, our results demonstrated that IL-17RA regulates
IFN-c production and tissue damage, at least in part, by recruiting
regulatory IL-10-producing neutrophils during T. cruzi infection.
Although the requirement of IL-10 to prevent inflammatory
damage and mortality during T. cruzi infection was reported many
years ago [32,33], our results provide important new information
about the sources of IL-10 and position neutrophils as an
important regulatory cells expanding our understanding of the
complex mechanisms that regulate inflammation during this
parasite infection. Furthermore, to our knowledge, this is the first
report linking IL-17-mediated protective effect during infections
with the recruitment of IL-10 producing neutrophils and the
consequent regulation of exacerbated type 1 inflammatory
responses. IL-17 producing T cells were reported to be protective
also in mycobacterial infection [66] where suppressive mechanisms
mediated by IL-10 secreting neutrophils were able to temper
pathological inflammatory responses but also to impair complete
bacterial clearance [61]. Considering these antecedents and our
results it is likely that the regulatory mechanism involving IL-17-
mediated recruitment of suppressor neutrophils may be extrapo-
lative to other infections where the balance between inflammation
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favors pathogen persistence and chronicity of the infection.
Materials and Methods
Ethic statement
All animal experiments were approved by and conducted in
accordance with guidelines of the Committee for Animal Care and
Use of the Facultad de Ciencias Quı ´micas, Universidad Nacional
de Co ´rdoba (Approval Number HCD 274/09) in strict accordance
with the recommendation of the Guide to the Care and Use of
Experimental Animals published by the Canadian Council on
Animal Care (OLAW Assurance number A5802-01).
Mice
IL-17RA deficient mice were provided by Amgen Inc through
Master Agreement Nu 200716544. IL-10 deficient mice were
purchased from The Jackson Laboratories (USA). C57BL/6 wild
type mice were obtained from School of Veterinary, La Plata
National University (La Plata, Argentina). All animals were housed
in the Animal Facility of the Facultad de Ciencias Quı ´micas,
Universidad Nacional de Co ´rdoba.
Parasites and experimental infection
Mice used for experiments were sex- and age-matched, and
housed with a 12-h light-dark cycle. Bloodstream trypomastigotes
of the Tulahue ´n strain of T. cruzi were obtained from BALB/c
mice infected 10 days earlier. Mice were inoculated intraperito-
neally (i.p.) with 0.2 ml PBS containing 3610
3 trypomastigotes.
Parasitemia was monitored by counting the number of viable
trypomastigotes in blood collected from the retrorbital sinus or tail
vein after lysis with a 0.87% ammonium chloride buffer. Mouse
survival was followed every day.
Cell preparation, sorting and culture
Spleen, liver and inguinal lymph nodes were obtained and
homogenized through a tissue strainer. Erythrocytes in spleen and
liver cell suspensions were lysed for 5 min in Tris-ammonium
chloride buffer. Liver infiltrating cells were obtained after 20 min
centrifugation (600 g) in a 35% and 70% bilayer Percoll (Sigma)
gradient. Bone marrow cells were isolated by flushing femurs and
tibias of mice with PBS-2%FBS. Viable cell numbers were
determined by trypan blue exclusion using a Neubauer counting
chamber. Cell subsets (NK cells, CD4 and CD8 T cells,
neutrophils and the remaining negative fraction) from spleen
and liver were purified to .98% by cell sorting after five color
staining using the following antibodies: CD11b-FITC, CD4-PE,
CD8-PECy7, CD3-PerCPCy5.5, NK1.1-Alexa Fluor 647
(eBioscience). Bone marrow neutrophils were isolated by positive
selection with anti-Ly6G-biotin and anti-biotin beads following
manufacturer’s instructions (Miltenyi Biotec). Purity of magnetic-
isolated neutrophils was higher than 95% as determined by flow
cytometry using CD11b, Ly-6G and Gr-1 staining (Figure S6A in
Text S1). Neutrophil viability was higher than 98% as determined
by trypan blue exclusion. Neutrophils from spleen and liver were
purified to .98% (Figure S6B in Text S1) by cell sorting after six-
color staining using the following antibodies: CD11b-FITC, CD4-
PE, CD3-PerCPCy5.5, B220-Alexa Fluor 647, Ly-6G-PE-Cy7,
Gr-1-Alexa Fluor 750 (eBioscience). For sorting experiments, at
least 3–5 mice were pooled by group. Cells were sorted with
FACSAria (BD Bioscience). Cells were cultured in RPMI 1640
(Gibco, Invitrogen) medium supplemented with 2 mM glutamine
(Gibco, Invitrogen), 50 mM 2-ME (Sigma), and 40 mg/ml
gentamicin (Fabra Laboratories) containing 10% FBS (PAA).
Cytokine and chemokine quantification
Cytokine-producing capacity of cell suspensions or purified
subsets was assessed after stimulation at a cell density of 1610
6
cell/ml. Cell suspension from spleen, lymph nodes and liver were
stimulated during 48 h with 2 mg/ml anti-CD3 Abs (BD
Biosciences) and 50 nM phorbol-12-13-dibutyrate (PdBU) (Sig-
ma). Alternatively, cells were stimulated with low doses PMA
(10 nM) and Ionomycin (0,5 mg/ml). Neutrophils were stimulated
during 48 h with 1 mg/ml Pam3CSK4 (Invivogen), and live
trypomastigotes (MOI 1:1). IFN-c, TNF, IL-10, IL-1b, IL-6 and
IL-17E concentrations in culture supernatants or in plasma were
assessed by ELISA using paired Abs or specific kits (eBiosciences)
according to standard protocols. IL-17A and IL17F concentra-
tions in culture supernatants or in serum were assessed using the
FlowCytomix Multiple Analyte Detection System (eBiosciences)
following manufacturer’s instruction. For chemokines and G-CSF
quantification, tissues were homogenized in PBS containing
0,5%BSA, 0,4M NaCl, 1 mM EDTA, 0,05% Tween 20 and a
protease inhibitor cocktail (Sigma-Aldrich) and centrifuged at
10000 g during 10 min (adapted from [67]). CXCL1 and G-CSF
were quantified in the supernatants using the CBA Assay from BD
Biosciences following manufacturer’s instruction. CXCL2 (MIP-2)
and CXCL10 (IP-10) were quantified using the specific ELISA kits
from Peprotech following manufacturer’s instruction. Chemokines
and G-CSF concentrations were normalized to total protein
concentration determined by Bradford’s technique (Biorad) in
tissue homogenates.
Flow cytometry
Cell suspensions were washed in ice-cold FACS buffer (PBS-2%
FBS) and incubated with fluorochrome labeled-Abs for 20 min at
4uC. Different combinations of the following Abs were used:
FITC-labeled: anti- CD19 or CD11b, PE-labeled: anti- CD11c or
CD4, PECy7-labeled: anti- Ly6G or CD8, PerCPCy5.5-labeled:
anti- CD4, CD3 or Ly6C, APC or Alexa Fluor 647-labeled: F4/
80, Alexa Fluor 750-labeled: anti Gr-1. Intracellular cytokines
were detected after stimulating cells during 5 hours with 50 nM
PMA and 0.5 mg/ml ionomycin (Sigma), 1 mg/ml Pam3CSK4
(Invivogen), and live trypomastigotes (MOI 1:1) in the presence of
GolgiStop (BD Biosciences). Cells were surface-stained, fixed and
permeabilized with BD Cytofix/Cytoperm and Perm/Wash (BD
Biosciences) according manufacturer’s instruction. Cells were
incubated with APC-labeled antibody to IFN-c, IL-17F or TNF
and PE-labeled antibody to IL-17A, IL-6, IL-12p70 or IL-10 (BD
Biosciences). Cells were acquired on FACSCanto II (BD
Bioscience).
Liver histology and transaminase activity
Livers obtained from WT and IL-17RA KO mice at different
times post T. cruzi infection were fixed in formaldehyde and
embedded in paraffin. Five-mm thick sections were examined by
light microscopy after hematoxylin/eosin staining. Double-blind
evaluation of liver damage focused in three main aspects: presence
and type of inflammatory infiltrate, presence and extension of
necrotic areas and hyaline degeneration and presence of cellular
alterations such as vacuolization, swelling, nuclear alterations, etc.
Photographs were taken using a Nikon Eclipse TE 2000 U
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transferase (AST) and alanine aminotransferase (ALT) activities
were measured using commercial kits (Wiener Lab) following
manufacturer’s instruction.
Cytospin of purified neutrophils
Two6105 sorted neutrophils were washed twice and dilute in
100 ml of ice-cold 2% FBS-PBS. Samples were aliquoted in the
appropriate cytospin clips and spun in a cytocentrifuge at medium
speed for 5–6 minutes. Slides were dried overnight, fixed with
methanol and stained with May-Gru ¨nwald/Giemsa following a
standard protocol.
Treatment with neutralizing or depleting Abs
IFN-c was neutralized in vivo by intraperitoneal injection of
250 mg of rat anti–mouse IFN-c mAb (clone R4-6A2) at days 9,
12, 15 and 18 post-infection. The delayed kinetic of neutralization
was chosen to allow an initial IFN-c response required to avoid
uncontrolled parasite spreading and early mortality. R4-6A2 mAb
was prepared from the eponymous cell clone and purified by
affinity chromatography using HiTrap Protein G columns (GE
Healthcare). As control, mice were injected with equal quantities
of normal rat IgG (Jackson ImmunoResearch). Mice were
sacrificed at day 20 post-infection. Neutrophil depletion was
achieved by intravenous injection of 250 mg rat anti-mouse Ly6G
(clone 1A8, BioXCell) mAb or normal rat IgG (Jackson
ImmunoResearch) as control at days 9, 12, 15 and 18 post-
infection. Mice were sacrificed at day 20 post-infection unless used
for survival monitoring. Neutrophil depletion efficiency was
evaluated by determining the presence of CD11b+Gr-1+Ly-6G+
cells by flow cytometry.
In vitro assessment of neutrophil regulatory activity
Splenocytes from normal WT mice were labeled with 0.5 mM
CFSE (carboxyfluorescein succinimidyl ester, Invitrogen). Spleen
CD11b+Ly-6G+ neutrophils were sorted from 20-day T. cruzi
infected WT and IL-17RA KO mice. CFSE stained splenocytes
(5610
5) and sorted neutrophils (1610
5) were cultured during 5
days in anti-CD3/anti-CD28 Ab coated (2 mg/ml each) 96-well
plates in the presence or absence of 10 mg/ml of a blocking anti-
IL-10R Ab (BD Biosciences). After culture, CFSE dilution and
intracellular IFN-c expression within de CD3 positive population
were assessed by flow cytometry. Proliferation data are presented
as relative to the percentage of CFSE-low CD3+ splenocytes in the
absence of neutrophils and anti-IL-10R Ab (set as 100%
proliferation).
Neutrophil adoptive transfer
To assess neutrophil recruitment to different tissues, bone
marrow neutrophils from WT were stained with CFSE and bone
marrow neutrophils from IL-17RA KO mice were stained with
SNARF-1 (Molecular Probes, Invitrogen) following conventional
protocols prior to injection in the retrorbital sinus of non-infected
and 20-day T. cruzi-infected WT and IL-17RA KO mice. Mice
were sacrificed 3 h after injection of 5610
6 CFSE-stained WT
neutrophils and of 5610
6 SNARF-stained IL-17RA KO neutro-
phils and the presence of transferred neutrophils were evaluated in
blood, bone marrow, liver and spleen. To evaluate the effect of
neutrophils adoptive transfer during T. cruzi infection, WT or IL-
17RA KO mice received four intravenous injections with a total of
5610
6 purified bone marrow WT neutrophils in 0,2 ml PBS at
days 9, 12, 15 and 18 post-infection. Injections were performed in
the retrorbital sinus alternating the eyes. In those adoptive transfer
experiment using WT and IL-10 KO neutrophils, 2610
6
neutrophils were injected. Control mice received 0,2 ml PBS.
Mice were sacrificed at day 20 post-infection unless used for
survival monitoring.
Statistics
Statistical significance of comparisons of mean values was
assessed by a two-tailed Student’s t test, two-way ANOVA
followed by Bonferroni’s posttest and a Gehan-Breslow-Wilcoxon
test using GraphPad software.
Accession numbers
B220/Ptprc (NM_001111316.1); CD11b/Integrin alpha M
(NM_001082960.1); CD11c/Integrin alpha X (NM_021334.2);
CD28 (NM_007642.4); CD3d (NM_013487.3); CD3e (NM_
007648.4); CD3g (NM_009850.2); CD4 (NM_013488.2); CD8a
(NM_001081110.2); CD8b.1 (NM_009858.2); CXCL1 (NM_
008176.3); CXCL10 (NM_021274.2); CXCL2 (NM_009140.2);
G-CSF (NM_009971.1); GM-CSF (NM_009969.4); IFNg (NM_
008337.3); IL10 (NM_010548.2); IL10RA (NM_008348.2); IL12a
(NM_001159424.1); IL12b.1 (NM_008353.2); IL17A (NM_
010552.3); IL17B (NM_019508.1); IL17C (NM_145834.3); IL17D
(NM_145837.3); IL17F (NM_145856.2); IL17RA (NM_008359.2);
IL17RB (NM_019583.3); IL17RC (NM_178942.1); IL17RD
(NM_134437.3); IL17RE (NM_145826.5); IL1b (NM_008361.3);
IL25/IL17E (NM_080729.3); IL27Ra (NM_016671.3); IL6
(NM_031168); Ly6c1 (NM_010741.3); Ly6G (XM_001475753.2/
XM_909927.3); NKRP1C (NM_001159904.1); TGFb.1 (NM_
011577.1); TNF (NM_013693.2).
Supporting Information
Text S1 Six supporting figures are available in Text S1. Figure
S1. Time course histological evaluation of hepatic
damage during T. cruzi infection. Photographs (2006)o f
Hematoxilin/Eosin stained liver sections from WT and IL-17RA
KO mice non-infected (NI) or after different times post T. cruzi
infection. Head arrows indicate focal inflammatory infiltrates.
Black lines delineate extensive necrotic areas. Stars indicated
hyaline degeneration. The analysis of the micrographs is
summarized in Table 1. Photographs are representative of one
out of five mice. Data is representative of two independent
experiments. Figure S2. Increased production of IFN-c in
T. cruzi infected IL-17RA KO mice. A) Expression of IFN-c
and CD3 after 5 h PMA/Ionomycin stimulation of spleen and
liver cell suspensions obtained from IL-17RA KO and WT mice
after 20 days of T. cruzi-infection. Plot representative of one out of
five mice. B) Concentration of IFN-c (left) and TNF (right)
detected in the supernantants of CD4+ and CD8+ T cells sorted
from spleen (top) and liver (bottom) of 20-day T. cruzi infected WT
and IL-17R KO mice and cultured for 48 h with anti-CD3 and
PDBu. Data are shown as mean 6 SD of triplicate cultures. P
values calculated with two-tailed T test. Data are representative of
three independent experiments. Figure S3. Phenotype and
morphology characterization of neutrophils infiltrating
liver and spleen during T. cruzi infection. A) Expression of
Ly-6G, Ly-6C, CD11c and F4/80 in the CD11b+Gr-1+ cells from
spleen and liver of 20-day T. cruzi infected WT and IL-17RA KO
mice. Dot plots and histograms are representative one out of five
mice per group. B) Morphology of the CD11b+Gr-1+ cells from
spleen and liver of 20- T. cruzi infected WT and IL-17RA KO
mice. Data in A–B are representative of two independent
experiments. Figure S4. Similar frequencies of
CD11b+Gr-1+ cell population in bone marrow and blood
IL-17RA Favors Regulatory Neutrophil Recruitment
PLoS Pathogens | www.plospathogens.org 15 April 2012 | Volume 8 | Issue 4 | e1002658of infected WT and IL-17RA KO mice. Percentage (A) and
absolute numbers (B) of CD11b+Gr-1hi neutrophils in the bone
marrow (left panels) and CD11b+Gr-1+ cells in the blood (right
panels) of WT and IL-17RA KO mice non-infected (NI) or after
20 days of T. cruzi infection. Dot plots are representative one out of
five mice per group. C) Concentration of G-CSF in spleen and
liver homogenates from non-infected (NI) or 20-day infected (I)
WT and IL-17RA KO mice. Data are shown as mean 6 SD of
biological triplicates, n=5 mice per group and normalized to total
protein concentration. P values calculated with two-tailed T test.
Data in A–B and in C are representative of four and two
independent experiments, respectively. Figure S5. Cytokine
production by bone marrow neutrophils stimulated with
live T. cruzi. Percentage of IL-10 (A), TNF and IL-6 (B) and IL-
12p70 (C) producing cells after 6 h stimulation with live T. cruzi
and Pam3CSK4 of Ly-6G+ neutrophils purified from bone
marrow of WT and IL-17RA KO mice. Plots are representative
of triplicate cultures. Data are representative of two independent
experiments. Figure S6. Purity of neutrophils after mag-
netic isolation and cell sorting. A) Purity of neutrophils
isolated from bone marrow of WT mice by magnetic positive
selection as determined by CD11b, Ly-6G and Gr-1 staining. B)
Purity of neutrophils isolated from spleen of WT mice by cell
sorting as determined by CD11b, Ly-6G and Gr-1 staining. Plots
are representative of all the purification experiments.
(PDF)
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